Dr Charalampos Konstantinidis graduated from medical school of University of Patra, Greece in 1996. He completed his training in Urology in 2004.
In 2005 he obtained the title of Fellow of the European Board of Urology (FEBU). He had post-graduated training through clinical fellowships at the Urology department of Nordwest Hospital in Frankfurt, Germany, at “Sava Perovic Foundation”, practicing in genito-urinary reconstructive surgery in Belgrade, Serbia and in Neuro-urology Unit of University hospital of Innsbruck, Austria.
Since August of 2006, he has been working as a consultant in Urology in the National Rehabilitation Center of Athens.
Dr Konstantinidis is an active member of boards and committees of national and international scientific societies and associations (HUA, EAU, ISSM, ESSM, ICS and INUS).
He has delivered more than a hundred lectures in the field of functional urology (Andrology, Sexual Medicine, Urodynamics, Incontinence, Neuro-urology). He has the authorship of 12 international publications and more than 30 ones in Greek.
He also participated as an author in more than 260 live, video or poster presentations in domestic and international congresses. He authored book chapters regarding neurourology and sexual function of paraplegics.
He studied biology in Heidelberg, Germany and obtained his PhD in Neuroscience from the University of California, San Diego, USA in 1987.
After postdoctoral work at the Salk Institute for Biological Studies in La Jolla, USA he returned to Germany as an independent research group leader at the Center for Molecular Biology in Heidelberg.
In 1998, he became full professor at the University of Heidelberg and was recruited one year later by the Max Planck Society to direct the Department of Neurogenetics at the Max Planck Institute of Experimental Medicine in Goettingen.
His research focuses on neuron-glia interactions, mechanisms of myelination, and rodent models of myelin diseases.
Recently, he discovered a role of oligodendrocytes in supporting axonal energy metabolism, which is also relevant for demyelinating diseases, such as multiple sclerosis.
Prof. Wiendl studied medicine in Germany, Switzerland and USA, graduating in 1996.
He has been a research fellow at the Institute of Neuroanatomy, Erlangen-Nuremberg, the Max Planck Institute for Neurobiology and the Department of Neurology Tuebingen, where he was a junior group leader for neuroimmunology, received his board certification and completed his habilitation.
He was appointed professor of neurology and head of the clinical research group for MS in Wuerzburg in 2005 and acted as a vice-chair of the Department of Neurology. In 2010 he was recruited to the University of Muenster as director of the Department of Neurology – Inflammatory Diseases of the Nervous System and Neurooncology. Since 2013 he is chair of the Department of Neurology in Muenster.
Prof. Wiendl’s research focuses on inflammatory neurodegeneration, immune regulation and protection, as well as monitoring multiple sclerosis (MS) and its therapy.
He co-founded the national German Competence Network of MS in 2009 and acts as a board member since. He is speaker of the comprehensive research center 128 “Multiple Sclerosis” funded by the German Research Foundation (DFG). His achievements have been recognised by several awards, among them both Sobek awards of the German Society for Multiple Sclerosis (DMSG).
More speaker bios will be available in due course.